Pharmacokinetics and safety of mavacamten in healthy Chinese participants with different CYP2C19 phenotypes
Abstract Obstructive hypertrophic cardiomyopathy (oHCM) is a subtype of HCM characterized by left ventricular outflow tract obstruction resulting from cardiac muscle hypertrophy and anatomic alterations in the mitral valve and apparatus. Mavacamten, a cardiac myosin inhibitor metabolized primarily b...
Saved in:
Main Authors: | Xiaojie Wu (Author), Nanye Chen (Author), Peiwen Hsu (Author), Jing Sun (Author), Wenting Li (Author), Qi Wang (Author), Merali Samira (Author), Qiong Wei (Author), Jicheng Yu (Author), Guoying Cao (Author), Haijing Yang (Author), Lili Wang (Author), Jingjing Wang (Author), Yi Jin (Author), Wei Liu (Author), Jufang Wu (Author), Jinjie He (Author), Cheng Lyu (Author), Jing Zhang (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
LZM008, a proposed tocilizumab biosimilar: Pharmacokinetics, safety, and immunogenicity profiles compared with ACTEMRA® in Chinese healthy male subjects
by: Guoying Cao, et al.
Published: (2023) -
Lefamulin dosing optimization using population pharmacokinetic and pharmacokinetic/pharmacodynamic assessment in Chinese patients with community-acquired bacterial pneumonia
by: Xingchen Bian, et al.
Published: (2024) -
Pharmacokinetics, Safety and Pharmacokinetics/Pharmacodynamics Analysis of Omadacycline in Chinese Healthy Subjects
by: Haijing Yang, et al.
Published: (2022) -
Pharmacokinetic, Pharmacokinetic/Pharmacodynamic, and Safety Investigations of Lefamulin in Healthy Chinese Subjects
by: Yingying Hu, et al.
Published: (2023) -
Characterization of mavacamten pharmacokinetics in patients with hypertrophic cardiomyopathy to inform dose titration
by: Peter Chang, et al.
Published: (2024)